Walleye Trading’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.32M Sell
14,200
-16,200
-53% -$2.49M ﹤0.01% 1614
2025
Q4
$5.29M Sell
30,400
-16,000
-34% -$2.92M 0.01% 1258
2025
Q3
$6.68M Sell
46,400
-95,900
-67% -$11.7M 0.01% 1097
2025
Q2
$14.3M Buy
142,300
+128,400
+924% +$9.82M 0.03% 669
2025
Q1
$1.06M Buy
13,900
+6,000
+76% +$459K ﹤0.01% 2024
2024
Q4
$545K Sell
7,900
-2,400
-23% -$173K ﹤0.01% 2573
2024
Q3
$752K Buy
10,300
+6,600
+178% +$487K ﹤0.01% 2272
2024
Q2
$248K Sell
3,700
-300
-8% -$11.6K ﹤0.01% 2951
2024
Q1
$109K Sell
4,000
-200
-5% -$5.6K ﹤0.01% 3732
2023
Q4
$130K Buy
+4,200
New +$109K ﹤0.01% 4026
2023
Q2
Sell
-5,300
Closed -$90.4K 4912
2023
Q1
$90.4K Buy
+5,300
New +$103K ﹤0.01% 3889
2021
Q2
Sell
-6,200
Closed -$211K 5339
2021
Q1
$211K Buy
+6,200
New +$237K ﹤0.01% 3561
2020
Q3
Sell
-40,400
Closed -$1.11M 4358
2020
Q2
$1.11M Buy
40,400
+36,200
+862% +$858K 0.01% 1572
2020
Q1
$67K Buy
+4,200
New +$99.6K ﹤0.01% 3318
2019
Q3
Sell
-29,400
Closed -$753K 4195
2019
Q2
$753K Buy
29,400
+22,700
+339% +$632K 0.01% 1837
2019
Q1
$195K Buy
+6,700
New +$174K ﹤0.01% 3046

Other funds holding INSM

Walleye Trading's INSM Position: Q1 2026 in Review

Walleye Trading reduced its Insmed (INSM) stake by 57% in Q1 2026, selling an estimated $1.54M and leaving 7,620 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2007.

Walleye Trading first reported a position in INSM in Q1 2019 and has held it in 13 quarters since. The position peaked at $3.07M in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Walleye Trading held 7,620 shares of Insmed worth $1.25M as of Q1 2026.
  • Walleye Trading sold 10,037 Insmed shares in Q1 2026, an estimated $1.54M.
  • Insmed made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #2007 holding.
  • Walleye Trading first reported a position in Insmed in Q1 2019 and has held it in 13 quarters since.
  • Walleye Trading's Insmed position peaked at $3.07M in Q4 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.